France has the second largest medical device (MD) market in Europe and fifth worldwide. The majority of the market share of the French MD market is supplied by both French-owned companies and increasing amount of foreign sales subsidiaries of multiple companies.
France uses a benefit rating system based on the assessment of actual benefit, and assessment of added clinical value in relation to the current gold standard, regardless of the current gold standard reimbursement arrangements.This rating system is used by the CNEDiMTS, a committee that gives guidance and recommendations on the framework of pricing and reimbursement (P&R) of a MD.
For a more detailed breakdown of France’s healthcare economy and med tech industry, refer to our France section on MAP Europe.
MAP Tag Cloud
Use the word cloud below to search for common topics – the larger the font, the more frequently it occurs.